- Home
- HWBK vs CMPX Comparison
HWBK vs CMPX Comparison
Compare HWBK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWBK
- CMPX
- Stock Information
- Founded
- HWBK 1865
- CMPX 2014
- Country
- HWBK United States
- CMPX United States
- Employees
- HWBK N/A
- CMPX N/A
- Industry
- HWBK Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- HWBK Finance
- CMPX Health Care
- Exchange
- HWBK Nasdaq
- CMPX Nasdaq
- Market Cap
- HWBK 242.4M
- CMPX 229.5M
- IPO Year
- HWBK N/A
- CMPX N/A
- Fundamental
- Price
- HWBK $29.20
- CMPX $1.75
- Analyst Decision
- HWBK
- CMPX Strong Buy
- Analyst Count
- HWBK 0
- CMPX 8
- Target Price
- HWBK N/A
- CMPX $13.38
- AVG Volume (30 Days)
- HWBK 17.1K
- CMPX 2.8M
- Earning Date
- HWBK 04-28-2025
- CMPX 05-12-2025
- Dividend Yield
- HWBK 2.60%
- CMPX N/A
- EPS Growth
- HWBK 1820.23
- CMPX N/A
- EPS
- HWBK 2.61
- CMPX N/A
- Revenue
- HWBK $71,882,000.00
- CMPX $850,000.00
- Revenue This Year
- HWBK N/A
- CMPX $47.65
- Revenue Next Year
- HWBK N/A
- CMPX $2,767.57
- P/E Ratio
- HWBK $11.20
- CMPX N/A
- Revenue Growth
- HWBK 36.16
- CMPX N/A
- 52 Week Low
- HWBK $17.86
- CMPX $0.77
- 52 Week High
- HWBK $35.95
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- HWBK 56.51
- CMPX 41.42
- Support Level
- HWBK $26.45
- CMPX $1.60
- Resistance Level
- HWBK $28.14
- CMPX $1.78
- Average True Range (ATR)
- HWBK 0.93
- CMPX 0.27
- MACD
- HWBK 0.32
- CMPX 0.03
- Stochastic Oscillator
- HWBK 90.31
- CMPX 38.01
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.